Reproductive issues for women with BRCA mutations
- PMID: 15784831
- DOI: 10.1093/jncimonographs/lgi012
Reproductive issues for women with BRCA mutations
Abstract
Women carrying BRCA1 and BRCA2 mutations face difficult and confusing reproductive decisions that fall into three categories: issues relating to risk-reducing surgeries, issues relating to use of oral contraceptives/tubal ligation, and issues relating to pregnancy and breastfeeding. Risk-reducing surgeries may confer survival benefits, but they also affect quality of life. Oral contraceptives potentially protect mutation carriers against ovarian cancer but increase the risk of early-onset breast cancer, and evidence for the efficacy of tubal ligation in reducing ovarian cancer risk in BRCA mutation carriers is contradictory. Women with BRCA mutations may increase their risk of breast cancer by becoming pregnant before age 40 years, but breastfeeding may decrease risk of breast cancer in women with BRCA mutations, regardless of age. BRCA mutation carriers desiring to become pregnant must deal with a variety of psychosocial issues, some with significant ethical implications, with minimal guidance from research.
Similar articles
-
Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.Gynecol Endocrinol. 2010 Aug;26(8):568-77. doi: 10.3109/09513590.2010.487609. Gynecol Endocrinol. 2010. PMID: 20632911 Review.
-
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352. Cancer. 2006. PMID: 17109443
-
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24. doi: 10.1158/1055-9965.EPI-09-0171. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19661091
-
A survey of preventive measures among BRCA1 mutation carriers from Poland.Clin Genet. 2007 Feb;71(2):153-7. doi: 10.1111/j.1399-0004.2007.00742.x. Clin Genet. 2007. PMID: 17250664
-
Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.Minerva Med. 2009 Oct;100(5):371-83. Minerva Med. 2009. PMID: 19910890 Review.
Cited by
-
BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).J Assist Reprod Genet. 2022 Jul;39(7):1433-1443. doi: 10.1007/s10815-022-02523-y. Epub 2022 Jun 4. J Assist Reprod Genet. 2022. PMID: 35661074 Free PMC article. Review.
-
Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.Fam Cancer. 2008;7(2):179-86. doi: 10.1007/s10689-007-9171-7. Epub 2007 Nov 17. Fam Cancer. 2008. PMID: 18026853
-
Genetics: breast cancer as an exemplar.Nurs Clin North Am. 2009 Sep;44(3):327-38. doi: 10.1016/j.cnur.2009.06.004. Nurs Clin North Am. 2009. PMID: 19683094 Free PMC article. Review.
-
Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer.Fam Cancer. 2009;8(4):441-9. doi: 10.1007/s10689-009-9263-7. Epub 2009 Jun 25. Fam Cancer. 2009. PMID: 19554475
-
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Mayo Clin Proc. 2010. PMID: 21123638 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous